Endologix (ELGX), TriVascular (TRIV) Enter Merger Agreement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
BMO Capital Downgrades Endologix (ELGX) to Market Perform
October 27, 2015 7:09 AM EDTBMO Capital downgraded Endologix (NASDAQ: ELGX) from Outperform to Market Perform with a price target of $12.00 (from $16.00).
For an analyst ratings summary and ratings history on Endologix click here. For more ratings news on Endologix click here.
Shares of Endologix closed at $13.73 yesterday.
... MoreTriVascular Technologies (TRIV) Prelim. Q3 Revenue Tops Estomates
October 26, 2015 4:05 PM EDTTriVascular Technologies (NASDAQ: TRIV) reported preliminary unaudited financial results for the third quarter ended September 30, 2015.
Preliminary revenue for the third quarter of 2015 is expected to be approximately $9.5 million, reflecting growth of 20% over the third quarter of 2014 on a reported basis and 23% on a... More
Endologix (ELGX) Tops Q3 EPS by 1c
October 26, 2015 4:03 PM EDTEndologix (NASDAQ: ELGX) reported Q3 EPS of ($0.13), $0.01 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $38.2 million versus the consensus estimate of $38.12 million.
For earnings history and earnings-related data on Endologix (ELGX) click here.
... More